Skip to content
LuckyFlow Blog

Zimbabwe Turns Down ‘One-Sided’ US Health Aid Agreement Over Data Concerns

Medical funding image
The proposed US funding was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a significant American health deal worth 367 million US dollars (£272m) spanning five years because of the United States' demand for sensitive information.

The decision was revealed after a official document from December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "lopsided".

A government spokesperson has since clarified that the United States was requesting genetic material for research and profit while refused to guarantee the resulting advantages from future medical innovations.

"We are forced to start the difficult and regrettable task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for more talks to reach a deal acceptable to all parties so the country's vital HIV programme can continue.

Wider Context

This development comes after a comparable situation in neighbouring Kenya, where a court blocked a similar deal with the US after legal challenges were filed about the security of citizens' medical information.

Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance transparency and accountability.

As per reports, Sixteen nations in Africa have so far agreed to these new agreements, constituting more than $18.3bn of fresh investment.

Details of the Declined Agreement

The funds for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration might have yielded significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy through US-supported initiatives," Tremont said.

However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.

"In essence, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our people should a new disease outbreak arise."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting frameworks already established through the global health agency.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.

"This system is intended to guarantee that when a nation contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to create them."

The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We welcome continued discussions with our US partners on how future co-operation could be structured in a manner that respects the independence and interests of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but recommended that negotiations must proceed since a large portion of the nation's HIV programmes depended on external financing.

"In cases where technical issues arise, such as those relating to information security or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," it commented.

The halted deal emphasises the continuing tensions between receiving crucial international aid and safeguarding local interests in an increasingly interconnected world.

By

Christine Brown

A senior web developer and digital strategist with over a decade of experience in creating user-centric online solutions.

LuckyFlow Blog

Type to search articles.